Trial intelligence / Profile preview

Vitamin C to reduce post-biopsy bleeding after percutaneous renal biopsy

ChiCTR2300079026Phase 3Not yet recruiting

Sponsor
Xijing Hospital
Start
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in Bleeding comparing Vitamin C arm with Placebo arm (2 arms). Primary endpoints: Severe bleeding events and Size of hematoma. Planned start Dec 2023; status: not yet recruiting.

02

Drugs

ascorbic acid
03

Conditions

Bleeding

Beyond the preview

Go deeper on ChiCTR2300079026.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300079026.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call